SCARCITY PROFILE — SCIENTIFIC LEADERSHIP

Olimpia Baranowska — CEO & Principal Scientist, Olympia Biosciences

Olimpia Baranowska

CEO · SCIENTIFIC DIRECTOR · FOUNDER

M.Sc. Eng. in Technical Physics and Applied Mathematics and Ph.D. Candidate in Medical Sciences (Phlebology), recognized in Rome for scientific excellence. Built a 17-year operating record while engineering a pure-play B2B CDMO model for defensible, clinical-grade IP mandates.

LEADERSHIP ACCESS PROTOCOL

Not a public founder inbox. A filtered scientific mandate pipeline.

The written brief is reviewed and routed to an appropriate IOC contact based on project phase and requirements.

AUTO-DECLINED INTAKE

  • GENERAL NETWORKING REQUESTS WITHOUT EXECUTION MANDATE
  • PRICE-FIRST OUTREACH WITHOUT CLINICAL OR IP THESIS
  • LOW-MOQ PRIVATE-LABEL INQUIRIES BELOW OUR MINIMUM RUN
  • FREE CONSULTATION EXPECTATIONS DISGUISED AS DUE DILIGENCE

ADMISSION REQUIREMENTS

BOARD-SPONSORED PROGRAM WITH BUDGET AUTHORITY
DEFENSIBLE SCIENTIFIC OR M&A-READY IP OBJECTIVE
READINESS FOR REGULATORY, QA, AND SCALE-UP GOVERNANCE
COMMITMENT TO START WITH PAID DUE DILIGENCE

CREDENTIAL MATRIX

Physics precision fused with medical rigor.

MSc ENGINEERING

APPLIED PHYSICS AND APPLIED MATHEMATICS — GDAŃSK UNIVERSITY OF TECHNOLOGY | DOUBLE SPECIALIZATION: ABSTRACT QUANTUM PHYSICS & ORGANIC MICROELECTRONICS

PHD TRACK

MEDICAL SCIENCES — DOCTORAL STUDIES | SPECIALIZATION: PHLEBOLOGY (BIOPHYSICS · PHARMACOGENETICS · CLINICAL EFFICACY)

STRATEGIC INNOVATIONS

Evidence-led work, defined by project scope.

FOUNDER SYNTHESIS

NON-LINEAR INTEGRATION OF PHYSICS, COLLAGEN BIOCHEMISTRY, PHLEBOLOGY AND MANUFACTURING.

HUMAN-LED, AI-ENABLED

HUMAN ORIGINALITY DEFINES DIRECTION; AI ACCELERATES EVIDENCE MAPPING.

PROJECT-SPECIFIC FORMULATION WORK

Formulation and delivery requirements are assessed against the product brief, evidence and agreed scope.

SCIENTIFIC PHILOSOPHY

“Formulation decisions should be considered against the product brief, available evidence and the agreed scope before a project moves to manufacturing.”
Olimpia Baranowska

Olimpia Baranowska

CEO & Scientific Director — IOC Ltd.

EXTERNAL VALIDATION

Recognition from institutions, not vanity rankings.

International Leader in Scientific Excellence

Rome, 22 October 2025

International Leader in Scientific Excellence in Dietary Supplement Manufacturing 2025 (gala in Rome, 22.10.2025).

Best in Business Award 2025

Międzynarodowa Agencja Rozwoju

Presented at the LET'S TALK ABOUT IT congress, Gliwice, 6.11.2025, under the honorary patronage of NCBR.

LEADERSHIP ACCESS

If your mandate is serious, initiate due diligence.

The written brief is reviewed and routed to an appropriate IOC contact based on project phase and requirements.

Frequently Asked Questions

Who is Olimpia Baranowska and what is her role at Olympia Biosciences™?
Olimpia Baranowska is Co-Founder, CEO and Scientific Director of Olympia Biosciences™. The International Leader in Scientific Excellence in Dietary Supplement Manufacturing 2025 gala took place in Rome on 22.10.2025.
What is the Zero Conflict of Interest model and why does it matter for supplement brands?
Olympia Biosciences™ has no brands of its own.
What scientific publications has Olimpia Baranowska authored?
Olimpia Baranowska has authored scientific and industry publications on collagen science (Biotechnologia.pl — 3 papers), pharmacogenetics and personalized medicine (Pharmaceutical Industry World), nervous system supplementation, hyperbaric oxygen therapy (Practical Physiotherapy), and collagen market analysis. Her research spans nutraceutical chemistry, biophysics, and clinical applications.
What international awards has Olimpia Baranowska and Olympia Biosciences™ received?
International Leader in Scientific Excellence in Dietary Supplement Manufacturing 2025 (gala in Rome, 22.10.2025); Best in Business Award 2025 (LET'S TALK ABOUT IT congress, Gliwice, 6.11.2025, under the honorary patronage of NCBR).